They reported slightly higher levels of carnitine in samples from high-grade gliomas compared with low-grade gliomas (a ratio of 4.21) and in the IDH wildtype compared with the IDH mutant (fold change of 3.91). This evidence concerns the gene IDH2 and glioma.